CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy

Hee Yeon Lee, Hoon-Kyo Kim, Kyung Hee Lee, Bong-Seog Kim, Hong Suk Song, Sung Hyun Yang, Joon Hee Kim, Yeul Hong Kim, Jong Gwang Kim, Sang-We Kim, Dong-Wan Kim, Si-Young Kim, Hee Sook Park

Cancer Research and Treatment. 2014;46(1):19-26. Published online 2014 January 15 DOI: https://doi.org/10.4143/crt.2014.46.1.19

A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy

Hee Yeon Lee, Hoon-Kyo Kim, Kyung Hee Lee, Bong-Seog Kim, Hong Suk Song, Sung Hyun Yang, Joon Hee Kim, Yeul Hong Kim, Jong Gwang Kim, Sang-We Kim, Dong-Wan Kim, Si-Young Kim, Hee Sook Park

Cancer Research and Treatment. 2014;46(1):19-26

Link1

Link2

Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study

Gábor Kovács, Antonio E Wachtel, Elena V Basharova, Tulla Spinelli, Pierre Nicolas, Edita Kabickova

The Lancet Oncology. 2016;17(3):332-344

Link1 Link2

A randomized, double blind, placebo-controlled study evaluating efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide

W. Nipondhkit

Annals of Oncology. 2018;29:ix131

Link1 Link2 Link3

A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy

T.J. Priestman, J.T. Roberts, B.K. Upadhyaya

Clinical Oncology. 1993;5(6):358-363

Link1 Link2

A Randomized Double-Dummy, Double Blind, Misoprostol Comparative Clinical Trial to Evaluate and Safety of Rebamipide in the Prevention of NSAID-Induced Gastrointestinal Complication

Jin Hwan Jung, Soo-Heon Park

Gastroenterology. 2011;140(5):S-572

Link1 Link2

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Annals of Oncology. 2014;25(1):300

Link1 Link2 Link3

Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy‐induced nausea and vomiting among children: A comparative randomized double‐blind controlled trial

Jittra Ruktrirong, Chanchai Traivaree, Chalinee Monsereenusorn, Apichat Photia, Nawachai Lertvivatpong, Piya Rujkijyanont

Pediatric Blood & Cancer. 2021;68(6):

Link1 Link2 Link3

Ondansetron Suppository: A Randomised, Double-Blind, Double-Dummy, Parallel-Group Comparison with Oral Ondansetron for the Prevention of Cyclophosphamide Induced Emesis and Nausea

N.G.P. Davidson, W. Paska, S. Van Belle, L. Goedhals, B. McQuade, J. McRae

Oncology. 1997;54(5):380-386

Link1 Link2

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

Mitsue Saito, Kenjiro Aogi, Ikuo Sekine, Hirohisa Yoshizawa, Yasuhiro Yanagita, Hiroshi Sakai, Kenichi Inoue, Chiyoe Kitagawa, Takashi Ogura, Shoichi Mitsuhashi

The Lancet Oncology. 2009;10(2):115-124

Link1 Link2

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

R. Gralla, M. Lichinitser, S. Van der Vegt, H. Sleeboom, J. Mezger, C. Peschel, G. Tonini, R. Labianca, A. Macciocchi, M. Aapro

Annals of Oncology. 2003;14(10):1570-1577

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.